日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis

局部前列腺癌根治性放疗联合雄激素剥夺疗法的最佳疗程:一项荟萃分析

Zaorsky, Nicholas G; Sun, Yilun; Nabid, Abdenour; Zapatero, Almudena; Bolla, Michel; Joseph, David; Maingon, Philippe; Guerrero, Araceli; Gonzalez, Ana Alvarez; San-Segundo, Carmen Gonzalez; Cabeza Rodríguez, Maria Ángeles; Sole, Josep Maria; Olivé, Agustí Pedro; Steigler, Allison; Souhami, Luis; Carrier, Nathalie; Armstrong, John G; Gillham, Charles; Pisansky, Thomas M; Schipper, Matthew; Sandler, Howard M; Efstathiou, Jason A; Lawton, Colleen; de Reijke, Theo M; Attard, Gerhardt; Roy, Soumyajit; Morgan, Scott C; Malone, Shawn; Hall, William A; Nguyen, Paul L; Shoag, Jonathan E; Vince, Randy A Jr; Calaway, Adam; Garcia, Jorge A; Barata, Pedro C; Mendiratta, Prateek; Brown, Jason R; Valle, Luca; Rettig, Matthew; Dess, Robert T; Jackson, William C; Martin, Ting; Jia, Angela Y; Steinberg, Michael; Romero, Tahmineh; Kishan, Amar U; Spratt, Daniel E

Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibition

转录组分析揭示AR抑制剂对AR阳性三阴性乳腺癌放射增敏的机制

McBean, Breanna; Hauk, Benjamin; Michmerhuizen, Anna R; Chandler, Benjamin C; Pesch, Andrea M; Lerner, Lynn M; Gurdak, Douglas; Ward, Connor; Rana, Priyanka; Zeidane, Reine Abou; Mercer, Vesna; Tao, Mingfang; Hochmuth, Ethan; Jungles, Kassidy M; The, Stephanie; Liu, Meilan; Spratt, Daniel E; Boyle, Alan P; Pierce, Lori J; Speers, Corey W

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes

ANPEP表达下调与侵袭性前列腺癌和不良疾病特异性预后相关

Putney, Ryan M; Trivedi, Purvish; Awasthi, Shivanshu; Serna, Amparo; Dhillon, Jasreman; Sweeney, Christopher J; Jeffrey Karnes, R; Cooperberg, Matthew R; Berlin, Alejandro; Nguyen, Paul L; Spratt, Daniel E; Davicioni, Elai; Proudfoot, James; Ryu, Monica; Katende, Esther; Park, Jong Y; Rebbeck, Timothy R; El-Kenawi, Asmaa; Yamoah, Kosj

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials

开发和验证一种人工智能数字病理生物标志物,用于预测高危前列腺癌男性患者在多项 III 期试验中从长期激素治疗和放射治疗中获益的情况

Armstrong, Andrew J; Liu, Vinnie Y T; Selvaraju, Ramprasaath R; Chen, Emmalyn; Simko, Jeffry P; DeVries, Sandy; Sartor, Oliver; Sandler, Howard M; Mohamad, Osama; Huang, Huei-Chung; Griffin, Jacqueline; Yamashita, Rikiya; Esteva, Andre; Tran, Phuoc T; Spratt, Daniel E; Carson, John Hi; Peters, Christopher; Gore, Elizabeth; Lee, Steve P; Monson, Jedidiah M; Augspurger, Mark E; El-Gayed, Ali; Rodgers, Joseph P; McKay, Rana; Morgan, Todd; Feng, Felix Y; Nguyen, Paul L

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

转移性激素敏感性前列腺癌早期前列腺特异性抗原反应的有利预测

Roy, Soumyajit; Sun, Yilun; Hussain, Maha; Chi, Kim N; Fizazi, Karim; Davis, Ian D; Halabi, Susan; Agarwal, Neeraj; Chowdhury, Simon; Tombal, Bertrand; Morgan, Scott C; Malone, Shawn; Barata, Pedro C; Ong, Michael; Wallis, Christopher J D; Berlin, Alejandro; Swami, Umang; Kishan, Amar U; Jia, Angela Y; Zaorsky, Nicholas G; Garcia, Jorge A; Mendiratta, Prateek; Brown, Jason R; Subhash, Vinod V; Stockler, Martin R; Thomas, Hayley; McKay, Rana R; Small, Eric J; Shore, Neal D; Saad, Fred; Sweeney, Christopher J; Spratt, Daniel E

Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment.

空间多组学识别出侵袭性前列腺癌的特征,突显了肿瘤微环境中的促炎趋化因子活性。

Krossa Sebastian, Andersen Maria K, Sandholm Elise M, Wess Maximilian, Kiviaho Antti, Sharma Abhibhav, Hakkola Sini, Hao Yangyang, Alshalalfa Mohammed, Davicioni Elai, Viset Trond, Størkersen Øystein, Karnes R Jeffrey, Spratt Daniel E, Giskeødegård Guro F, Nykter Matti, Rye Morten B, Urbanucci Alfonso, Tessem May-Britt

Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials

TITAN 和 SPARTAN 试验中他汀类药物在晚期前列腺癌患者中的应用

Roy, Soumyajit; Ozay, Zeynep Irem; Guha, Avirup; Sun, Yilun; Chi, Kim N; Morgan, Scott C; Malone, Shawn; Wallis, Christopher J D; Brown, Jason R; Barata, Pedro C; Kishan, Amar U; Jia, Angela Y; Zaorsky, Nicholas G; Swami, Umang; Chowdhury, Simon; Small, Eric J; Spratt, Daniel E; Saad, Fred; Agarwal, Neeraj

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

NRG Oncology/RTOG 0521 3期试验表明,局部高危前列腺癌的转录组分析可改善预后,并揭示在根治性放疗联合雄激素抑制治疗中加入多西他赛的益处。

Phillips, Ryan M; Proudfoot, James A; Davicioni, Elai; Liu, Yang; Spratt, Daniel E; Simko, Jeff M; Den, Robert B; Pollack, Alan; Rosenthal, Seth A; Sartor, A Oliver; Sweeney, Christopher J; Attard, Gerhardt; Longoria, Leslie; Patel, Samir; Straza, Michael W; Efstathiou, Jason A; Shah, Amit B; Hoffman, Karen E; Rodgers, Joseph P; Sandler, Howard M; Feng, Felix Y; Tran, Phuoc T

The Benefit of Short-Term Androgen Deprivation Therapy with Radiation Therapy for Intermediate-Risk Prostate Cancer

短期雄激素剥夺疗法联合放射疗法对中危前列腺癌的益处

Patel, Krishnan R; Spratt, Daniel E; Tran, Phuoc T; Krauss, Daniel J; D'Amico, Anthony V; Nguyen, Paul L

Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)

高危前列腺癌男性患者剂量递增放射治疗联合标准雄激素剥夺疗法与剂量递增放射治疗联合奥特罗内尔强化雄激素剥夺疗法的 3 期试验 (NRG/RTOG 1115)

Hamstra, Daniel A; Dignam, James J; Bruner, Deborah W; Michaelson, M Dror; Bachand, François; Master, Viraj; Torres, Mylin A; Saylor, Philip J; Wallace, Robert E; Vapiwala, Neha; Efstathiou, Jason A; Roach, Mack 3rd; Rosenthal, Seth A; Raben, Adam; Morgan, Scott C; Kavadi, Vivek S; Spratt, Daniel E; Michalski, Jeff M; Seiferheld, Wendy; Pugh, Stephanie L; Movsas, Benjamin; Sandler, Howard